Tandem Diabetes Care, Inc. (LON:0M0F)

Tandem Diabetes Care Statistics

Total Valuation

LON:0M0F has a market cap or net worth of GBP 1.11 billion. The enterprise value is 1.23 billion.

Market Cap	1.11B
Enterprise Value	1.23B

Important Dates

The last earnings date was Thursday, February 19, 2026.

Earnings Date	Feb 19, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	68.33M
Shares Outstanding	n/a
Shares Change (YoY)	+2.80%
Shares Change (QoQ)	+0.54%
Owned by Insiders (%)	1.04%
Owned by Institutions (%)	103.73%
Float	62.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.48
PB Ratio	9.67
P/TBV Ratio	10.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.11
EV / Sales	1.61
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-55.92

Financial Position

The company has a current ratio of 2.55, with a Debt / Equity ratio of 2.90.

Current Ratio	2.55
Quick Ratio	1.89
Debt / Equity	2.90
Debt / EBITDA	n/a
Debt / FCF	-15.15
Interest Coverage	-9.88

Financial Efficiency

Return on equity (ROE) is -97.88% and return on invested capital (ROIC) is -26.94%.

Return on Equity (ROE)	-97.88%
Return on Assets (ROA)	-5.28%
Return on Invested Capital (ROIC)	-26.94%
Return on Capital Employed (ROCE)	-12.24%
Weighted Average Cost of Capital (WACC)	10.66%
Revenue Per Employee	301,580
Profits Per Employee	-60,840
Employee Count	2,500
Asset Turnover	1.10
Inventory Turnover	3.37

Taxes

In the past 12 months, LON:0M0F has paid 3.30 million in taxes.

Income Tax	3.30M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +11.59% in the last 52 weeks. The beta is 1.67, so LON:0M0F's price volatility has been higher than the market average.

Beta (5Y)	1.67
52-Week Price Change	+11.59%
50-Day Moving Average	21.49
200-Day Moving Average	17.72
Relative Strength Index (RSI)	48.45
Average Volume (20 Days)	4,083

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.24

Income Statement

In the last 12 months, LON:0M0F had revenue of GBP 753.95 million and -152.10 million in losses. Loss per share was -2.26.

Revenue	753.95M
Gross Profit	405.69M
Operating Income	-58.04M
Pretax Income	-148.80M
Net Income	-152.10M
EBITDA	-44.92M
EBIT	-58.04M
Loss Per Share	-2.26

Balance Sheet

The company has 217.45 million in cash and 333.89 million in debt, with a net cash position of -116.43 million.

Cash & Cash Equivalents	217.45M
Total Debt	333.89M
Net Cash	-116.43M
Net Cash Per Share	n/a
Equity (Book Value)	115.29M
Book Value Per Share	1.69
Working Capital	278.94M

Cash Flow

In the last 12 months, operating cash flow was -7.22 million and capital expenditures -14.82 million, giving a free cash flow of -22.04 million.

Operating Cash Flow	-7.22M
Capital Expenditures	-14.82M
Free Cash Flow	-22.04M
FCF Per Share	n/a

Margins

Gross margin is 53.81%, with operating and profit margins of -7.70% and -20.17%.

Gross Margin	53.81%
Operating Margin	-7.70%
Pretax Margin	-19.74%
Profit Margin	-20.17%
EBITDA Margin	-5.96%
EBIT Margin	-7.70%
FCF Margin	n/a

Dividends & Yields

LON:0M0F does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.80%
Shareholder Yield	-2.80%
Earnings Yield	-13.65%
FCF Yield	-1.98%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0M0F has an Altman Z-Score of 0.48 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.48
Piotroski F-Score	3